welcome
Yahoo Finance

Yahoo Finance

Health

Health

Novavax reports large quarterly revenue declines, rethinks its strategic direction

Yahoo Finance
Summary
Nutrition label

87% Informative

Novavax reported $88 million in revenues in the fourth quarter , compared to $291 million the year prior .

The sharp decline reflected slumping sales of its COVID-19 vaccine.

Sales figures also reflected revenues of $200 million from the sale of a manufacturing facility in the Czech Republic to Novo Nordisk .

CEO John Jacobs said he is still getting support from the federal government to develop the company's pandemic flu vaccine.

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.